Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

57 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide.
Paganelli G, Zoboli S, Cremonesi M, Bodei L, Ferrari M, Grana C, Bartolomei M, Orsi F, De Cicco C, Mäcke HR, Chinol M, de Braud F. Paganelli G, et al. Among authors: macke hr. Eur J Nucl Med. 2001 Apr;28(4):426-34. doi: 10.1007/s002590100490. Eur J Nucl Med. 2001. PMID: 11357492 Clinical Trial.
Internalization of [DOTA degrees,125I-Tyr3]Octreotide by somatostatin receptor-positive cells in vitro and in vivo: implications for somatostatin receptor-targeted radio-guided surgery.
Hofland LJ, Breeman WA, Krenning EP, de Jong M, Waaijers M, van Koetsveld PM, Mäcke HR, Lamberts SW. Hofland LJ, et al. Among authors: macke hr. Proc Assoc Am Physicians. 1999 Jan-Feb;111(1):63-9. doi: 10.1046/j.1525-1381.1999.09110.x. Proc Assoc Am Physicians. 1999. PMID: 9893158
57 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page